Christen Samuel E, Scanniello Elisabetta, Hammann Felix, Meyer-Massetti Carla, Auer Reto, Etter Jean-François, Liakoni Evangelia
Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
Tob Induc Dis. 2025 Jul 24;23. doi: 10.18332/tid/204839. eCollection 2025.
Despite the important role that healthcare professionals play in smoking cessation strategies, recent reports from several countries show misperceptions about nicotine, pharmacotherapy for smoking cessation and novel nicotine products, but little is known about such knowledge gaps among healthcare professionals in Switzerland.
This study involved a cross-sectional anonymous survey. Physicians and pharmacists from a large hospital group in Switzerland were invited in 2023 by e-mail to participate. The survey covered nicotine, smoking cessation, and knowledge of electronic nicotine delivery systems (ENDS).
Of the 2035 healthcare professionals contacted, 279 responded to the survey (14%). Fifty-three percent of participants identified as women, 69% were in the age group of ≤40 years, 77% were never smokers, and 85% saw patients daily. The majority (76%) agreed that nicotine is the main substance in tobacco responsible for addiction, while 73% and 69% disagreed that nicotine on its own causes cancer or chronic obstructive pulmonary disease (COPD), respectively. Most participants (n=128; 63%) opposed the recommendation of e-cigarettes as a smoking cessation aid, although e-cigarettes were considered less harmful than combustible cigarettes, both for users and bystanders. Nevertheless, 64% considered them to be equally or more problematic for public health than tobacco cigarettes.
This survey highlights knowledge gaps and misperceptions about nicotine and smoking cessation products among healthcare professionals in a large hospital group in Switzerland. Respondents appeared to have a relative accurate understanding regarding most of the direct effects of nicotine. However, uncertainties were noted in relation to newer products such as e-cigarettes. Future research should extend to other healthcare professionals and assess the impact of targeted training on knowledge and clinical practice.
尽管医疗保健专业人员在戒烟策略中发挥着重要作用，但来自几个国家的近期报告显示，人们对尼古丁、戒烟药物治疗和新型尼古丁产品存在误解，而对于瑞士医疗保健专业人员中的此类知识差距却知之甚少。
本研究采用横断面匿名调查。2023年通过电子邮件邀请了瑞士一家大型医院集团的医生和药剂师参与。该调查涵盖了尼古丁、戒烟以及电子尼古丁传送系统（ENDS）的知识。
在联系的2035名医疗保健专业人员中，有279人回复了调查（14%）。53% 的参与者为女性，69% 年龄在40岁及以下，77% 从不吸烟，85% 每天都看诊患者。大多数人（76%）认为尼古丁是烟草中导致成瘾的主要物质，而分别有73% 和69% 的人不同意尼古丁本身会导致癌症或慢性阻塞性肺疾病（COPD）的观点。大多数参与者（n = 128；63%）反对将电子烟作为戒烟辅助工具的建议，尽管电子烟被认为对使用者和旁观者的危害都小于可燃香烟。尽管如此，64% 的人认为电子烟对公众健康的问题与烟草香烟相当或更大。
这项调查凸显了瑞士一家大型医院集团的医疗保健专业人员在尼古丁和戒烟产品方面的知识差距和误解。受访者似乎对尼古丁的大多数直接影响有相对准确的理解。然而，对于电子烟等新产品仍存在不确定性。未来的研究应扩展到其他医疗保健专业人员，并评估针对性培训对知识和临床实践的影响。
Zotero 插件
